WAKE FOREST, N.C. | ADELAIDE, AUS, June 4, 2024 – (ACN Newswire) – Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, is sharing new data at BIO 2024 from Frost & Sullivan research showing biotechs save more than 30% in costs and halve start-up times with CROs that have in-house scientific and regulatory affairs. Meet the team at BIO 2024 Booth #5601 DOWNLOAD THE REPORT HERE According to the report key benefits for biotechs with CROs that have in-house scientific and regulatory affairs included: Decrease trial startup timelines by up to 50% by sup…
